These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8944256)

  • 1. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand.
    Songsivilai S; Dharakul T; Kanistanon D
    Trans R Soc Trop Med Hyg; 1996; 90(5):505-7. PubMed ID: 8944256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of hepatitis B virus DNA and hepatitis C virus RNA in human hepatocellular carcinoma by polymerase chain reaction].
    Zhang H; Tang Y; Lu X
    Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):70-2. PubMed ID: 9206206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand.
    Barusrux S; Nanok C; Puthisawas W; Pairojkul C; Poovorawan Y
    Asian Pac J Cancer Prev; 2012; 13 Suppl():83-7. PubMed ID: 23480769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
    Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
    Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
    Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
    J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
    Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
    Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
    Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
    Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
    Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
    J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.
    Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ
    Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
    Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
    Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
    Weinig M; Hakim JG; Gudza I; Tobaiwa O
    Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
    Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.